Mark N Wass (Mark Wass)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 14

Top Topics

Binding Protein

Cell Proliferation

Human Serum Albumin

Top Venues

Beilstein journal of nanotechnology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ankur Chakravarthy, Ian Reddin, Stephen Henderson, Cindy Dong, Nerissa Kirkwood, Maxmilan Jeyakumar, Daniela Rothschild Rodriguez, Natalia Gonzalez Martinez, Jacqueline McDermott, Xiaoping Su, Nagayasau Egawa, Christina S Fjeldbo, Vilde Eide Skingen, Heidi Lyng, Mari Kyllesø Halle, Camilla Krakstad, Afschin Soleiman, Susanne Sprung, Matt Lechner, Peter J I Ellis, Mark N Wass, Martin Michaelis, Heidelinde Fiegl, Helga Salvesen, Gareth J Thomas, John Doorbar, Kerry Ann Chester, Andrew Feber, Tim R Fenton
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. Nature communications 13 (1) (2022)
Jake E McGreig, Hannah Uri, Magdalena Antczak, Michael J E Sternberg, Martin Michaelis, Mark N Wass
3DLigandSite: structure-based prediction of protein-ligand binding sites. Nucleic acids research (2022)
Katie-May McLaughlin, Denisa Bojkova, Joshua D Kandler, Marco Bechtel, Philipp Reus, Thi Trang Le, Florian Rothweiler, Julian U G Wagner, Andreas Weigert, Sandra Ciesek, Mark N Wass, Martin Michaelis, Jindrich Cinatl
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis. Current issues in molecular biology 43 (3) (2021)
Chloe A Johnson, Jake E McGreig, Sarah T Jeanfavre, Jonathan Walklate, Carlos D Vera, Marta Farré, Daniel P Mulvihill, Anthony J Baines, Martin Ridout, Leslie A Leinwand, Mark N Wass, Michael A Geeves
Identification of sequence changes in myosin II that adjust muscle contraction velocity. PLoS biology 19 (6) (2021)
Hisham Saafan, Ahmad Alahdab, Robin Michelet, Linus Gohlke, Janine Ziemann, Stefan Holdenrieder, Katie-May McLaughlin, Mark N Wass, Jindrich Cinatl, Martin Michaelis, Charlotte Kloft, Christoph A Ritter
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line. Cells 10 (4) (2021)
Jane Louise Ward, Yanqi Wu, Claudia Harflett, Hannah Onafuye, Delia Corol, Charlotte Lomax, William J Macalpine, Jindrich Cinatl, Mark N Wass, Martin Michaelis, Michael H Beale
Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy. Scientific reports 10 (1) (2020)
Martin Michaelis, Yvonne Voges, Florian Rothweiler, Fabian Weipert, Amara Zia-Ahmad, Jaroslav Cinatl, Andreas von Deimling, Frank Westermann, Franz Rödel, Mark N Wass, Jindrich Cinatl
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines. Cancers 12 (3) (2020)
Tamara Rothenburger, Katie-May McLaughlin, Tobias Herold, Constanze Schneider, Thomas Oellerich, Florian Rothweiler, Andrew Feber, Tim R Fenton, Mark N Wass, Oliver T Keppler, Martin Michaelis, Jindrich Cinatl
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine. Communications biology 3 (1) (2020)
Denisa Bojkova, Marco Bechtel, Katie-May McLaughlin, Jake E McGreig, Kevin Klann, Carla Bellinghausen, Gernot G U Rohde, Danny Jonigk, Peter Braubach, Sandra Ciesek, Christian Münch, Mark N Wass, Martin Michaelis, Jindrich Cinatl
Aprotinin Inhibits SARS-CoV-2 Replication. Cells 9 (11) (2020)
Katie-May McLaughlin, Marco Bechtel, Denisa Bojkova, Christian Münch, Sandra Ciesek, Mark N Wass, Martin Michaelis, Jindrich Cinatl
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link? Diagnostics (Basel, Switzerland) 10 (8) (2020)
Hannah Onafuye, Sebastian Pieper, Dennis Mulac, Jindrich Cinatl, Mark N Wass, Klaus Langer, Martin Michaelis
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells. Beilstein journal of nanotechnology 10 (2019)
Sebastian Pieper, Hannah Onafuye, Dennis Mulac, Jindrich Cinatl, Mark N Wass, Martin Michaelis, Klaus Langer
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity. Beilstein journal of nanotechnology 10 (2019)
Jane F Povey, Emily Saintas, Adewale V Aderemi, Florian Rothweiler, Richard Zehner, Wilhelm G Dirks, Jindrich Cinatl, Andrew J Racher, Mark N Wass, Christopher Mark Smales, Martin Michaelis
Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines. Cells 8 (10) (2019)
Magdalena Antczak, Martin Michaelis, Mark N Wass
Environmental conditions shape the nature of a minimal bacterial genome. Nature communications 10 (1) (2019)